During the past decade, Barrie GI Associates conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 2 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Barrie GI Associates" #1 sponsor was "Janssen Research & Development, LLC" with 3 trials, followed by "Celgene" with 2 trials sponsored, "Galapagos NV" with 2 trials sponsored, "Ferring Pharmaceuticals" with 1 trials sponsored and "Takeda" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Barrie GI Associates" #1 collaborator was "Gilead Sciences" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Barrie GI Associates" are "Crohn's Disease" (4 trials), "Crohn Disease" (3 trials), "Active Ulcerative Colitis" (1 trials), "Remission of Ulcerative Colitis" (1 trials) and "Ulcerative Colitis" (1 trials). Many other conditions were trialed in "Barrie GI Associates" in a lesser frequency.

Most popular intervention types in "Barrie GI Associates" are "Drug" (8 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Guselkumab" (3 trials), "Filgotinib" (2 trials), "GED-0301" (2 trials) and "5-ASA (5-Aminosalicylate)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Barrie GI Associates" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Barrie GI Associates". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 2 completed trials in Barrie GI Associates, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Barrie GI Associates, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".